CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage. Issue 6 (23rd April 2020)
- Record Type:
- Journal Article
- Title:
- CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage. Issue 6 (23rd April 2020)
- Main Title:
- CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage
- Authors:
- Kodama, Kazuki
Takahashi, Hiroaki
Oiji, Nobuyasu
Nakano, Kenta
Okamura, Tadashi
Niimi, Kimie
Takahashi, Eiki
Guo, Long
Ikegawa, Shiro
Furuichi, Tatsuya - Abstract:
- Abstract : Desbuquois dysplasia (DD) type 1 is a rare skeletal dysplasia characterized by a short stature, round face, progressive scoliosis, and joint laxity. The causative gene has been identified as calcium‐activated nucleotidase 1 ( CANT1 ), which encodes a nucleotidase that preferentially hydrolyzes UDP to UMP and phosphate. In this study, we generated Cant1 KO mice using CRISPR/Cas9‐mediated genome editing. All F0 mice possessing frameshift deletions at both Cant1 alleles exhibited a dwarf phenotype. Germline transmission of the edited allele was confirmed in an F0 heterozygous mouse, and KO mice were generated by crossing of the heterozygous breeding pairs. Cant1 KO mice exhibited skeletal defects, including short stature, thoracic kyphosis, and delta phalanx, all of which are observed in DD type 1 patients. The glycosaminoglycan (GAG) content and extracellular matrix space were reduced in the growth plate cartilage of mutants, and proliferating chondrocytes lost their typical flat shape and became round. Chondrocyte differentiation, especially terminal differentiation to hypertrophic chondrocytes, was impaired in Cant1 KO mice. These findings indicate that CANT1 is involved in the synthesis of GAG and regulation of chondrocyte differentiation in the cartilage and contribute to a better understanding of the pathogenesis of DD type 1. Abstract : Mutations in the gene encoding for CANT1 (calcium‐activated nucleotidase 1) are responsible for Desbuquois dysplasia (DD)Abstract : Desbuquois dysplasia (DD) type 1 is a rare skeletal dysplasia characterized by a short stature, round face, progressive scoliosis, and joint laxity. The causative gene has been identified as calcium‐activated nucleotidase 1 ( CANT1 ), which encodes a nucleotidase that preferentially hydrolyzes UDP to UMP and phosphate. In this study, we generated Cant1 KO mice using CRISPR/Cas9‐mediated genome editing. All F0 mice possessing frameshift deletions at both Cant1 alleles exhibited a dwarf phenotype. Germline transmission of the edited allele was confirmed in an F0 heterozygous mouse, and KO mice were generated by crossing of the heterozygous breeding pairs. Cant1 KO mice exhibited skeletal defects, including short stature, thoracic kyphosis, and delta phalanx, all of which are observed in DD type 1 patients. The glycosaminoglycan (GAG) content and extracellular matrix space were reduced in the growth plate cartilage of mutants, and proliferating chondrocytes lost their typical flat shape and became round. Chondrocyte differentiation, especially terminal differentiation to hypertrophic chondrocytes, was impaired in Cant1 KO mice. These findings indicate that CANT1 is involved in the synthesis of GAG and regulation of chondrocyte differentiation in the cartilage and contribute to a better understanding of the pathogenesis of DD type 1. Abstract : Mutations in the gene encoding for CANT1 (calcium‐activated nucleotidase 1) are responsible for Desbuquois dysplasia (DD) type 1. Cant1 KO mice exhibit skeletal defects that recapitulate DD type 1. Reduced glycosaminoglycan (GAG) content and impaired chondrocyte differentiation are observed in the growth plate cartilage of these mutants. These findings indicate that CANT1 is involved in the synthesis of GAG and regulation of chondrocyte differentiation. … (more)
- Is Part Of:
- FEBS open bio. Volume 10:Issue 6(2020)
- Journal:
- FEBS open bio
- Issue:
- Volume 10:Issue 6(2020)
- Issue Display:
- Volume 10, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 10
- Issue:
- 6
- Issue Sort Value:
- 2020-0010-0006-0000
- Page Start:
- 1096
- Page End:
- 1103
- Publication Date:
- 2020-04-23
- Subjects:
- CANT1 -- chondrocyte -- Desbuquois dysplasia -- extracellular matrix -- genome editing -- glycosaminoglycan
Molecular biology -- Periodicals
Cytology -- Periodicals
Life sciences -- Periodicals
Biological Science Disciplines -- Periodicals
Molecular Biology -- Periodicals
Cell Biology -- Periodicals
Cytology
Life sciences
Molecular biology
Periodicals
572.805 - Journal URLs:
- http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2211-5463/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/2211-5463.12859 ↗
- Languages:
- English
- ISSNs:
- 2211-5463
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14823.xml